期刊文献+

PTEN蛋白磷酸酶活性的作用 被引量:2

The Function of PTEN’s Protein Phosphatase Activity
原文传递
导出
摘要 PTEN是一个具有磷酸酶活性的肿瘤抑制基因,是编码具有脂质磷酸酶活性和蛋白磷酸酶活性的双重特异性磷酸酶,其缺失或功能异常与人类恶性肿瘤的发生发展密切相关。PTEN的脂质磷酸酶活性和蛋白磷酸酶活性在调控肿瘤细胞的生物学行为、维持细胞正常的生理活动中均发挥了重要作用。但二者的作用重点及机制仍有不同,其蛋白磷酸酶活性主要侧重于调控细胞的黏附迁移及侵袭。为更好地认识PTEN蛋白磷酸酶活性的作用,该文对PTEN蛋白磷酸酶活性的作用及其机制作一简要综述。 Phosphatase and tensin homolog deleted on chromosome ten (PTEN), a tumor suppressor gene found to exhibit a dual specificity protein and lipid phosphatase activity, occurs deletion or dysfunction in a wide range of advanced cancers. Both lipid phosphatase activity and protein phosphatase activity of PTEN playan important role in regulating the biological behavior of tumor cell and maintaining normal cellular physiologic function. However, there are differences between lipid phosphatase activity and protein phosphatase activity in the focal point and mechanism of the function. And the function of its protein phosphatase activity is mainly to regulatethe adhesion, migration and invasion of cell. In this article, the funcion of PTEN's protein phosphatase activity andits mechanisms were briefly summarized for a better understanding of its role.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2012年第1期85-90,共6页 Chinese Journal of Cell Biology
基金 国家自然科学基金(No.30872513) 河北省自然基金(No.C2010000565)资助项目~~
关键词 PTEN 蛋白磷酸酶活性:信号转导 PTEN protein phosphatase activity signal transduction
作者简介 通讯作者:张晓岚。Tel:0311-66002955,E-mail:xiaolanzh@126.com
  • 相关文献

参考文献4

二级参考文献30

  • 1White ES, Atrasz RG, Hu B, et al. Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med, 2006, 173: 112-121.
  • 2Crackower MA, Oudit GY, Kozieradzki I, et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell, 2002, 110: 737-749.
  • 3Moezi L, Gaskari SA, Liu H, et al. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors. Br J Pharmacol, 2006, 149: 898-908.
  • 4Arocho A, Chcn B, Ladanyi M, et al. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol, 2006, 15: 56-61.
  • 5Marsit C J, Zheng S, Aldape K, et al. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol, 2005, 36: 768- 776.
  • 6Hu TH, Huang CC, Lin PR, et al. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEPI in hepatocellular carcinoma. Cancer, 2003, 97: 1929-1940.
  • 7Watanabe S, Horie Y, Kataoka E, et al. Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatasc and tensin homolog (PTEb0-deficient mice. J Gastroenterol Hepatol, 2007, 22 Suppl 1: S96-S100.
  • 8Sarem M, Znaidak R, Macias M, et al. Hepatic stellate cells: it's role in normal and pathological conditions. Gastroentero Hepatol, 2006, 29: 93-101.
  • 9Urtasun R, Nieto N. Hepatic stellate cells and oxidative stress. Rev Esp Enferm Dig, 2007 99: 223-230.
  • 10Teunissen BE, Smeets P J, Willemsen PH, et al. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Cardiovasc Res, 2007, 75: 519-529.

共引文献51

同被引文献62

  • 1张丹丹,郭琳,王强.肿瘤抑制基因PTEN的研究现状[J].现代肿瘤医学,2007,15(1):108-111. 被引量:6
  • 2季幸姝,吴仕九.膈下逐瘀汤对肝癌Bel-7402细胞增殖的抑制及与磷酸化AKT的相关性研究[J].新中医,2007,39(3):101-103. 被引量:4
  • 3张春虎,胡随瑜,曹美群,林源,李云辉.丹皮酚对肝癌MHCC97-H细胞PTEN、AKT表达的影响[J].现代生物医学进展,2007,7(8):1134-1137. 被引量:9
  • 4梁玉梅,李向红.抑癌基因PTEN调控机制研究进展[J].国际病理科学与临床杂志,2007,27(5):397-400. 被引量:4
  • 5Manning BD, Cantley LC. AKT/PKB signaling:navigating downstream [J].Cell, 2007,129(7):1261-1274.
  • 6Kenry M, Parsons R. The role of PTEN signaling perturbations in cancer and in targeted therapy [J]. Oncogene, 2008,27:5477-5485.
  • 7Ali I U, Schriml L M, Dean M. Mutational spectra of PTEN /MMACI gene:a tumor suppressor with lipid phosphatasc activity[J]. J Natl Cancer Inst, 1999,91 (22):1922-1932.
  • 8Hlobilkov A, Knillova J, Bartek J, Lukas J, Kolar Z. The mechanism of action of the tumour suppressor gene PTEN. Biomed Pap Med Fac Univ Palacky 01omouc CzechRepub, 2003, 147(1) : 19-25.
  • 9James A. Mccubery, Linda S Steelman, Steven L. Abrams, et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/AKT patnways in malignant transformation and drug resistance[J].Adv Enzyme Regul, 2006,46:249-279.
  • 10Blaneo-Aparieio C, Renner O, Leal J F, et al. PTEN, more than the akt pathway [J].Careinogenesis, 2007,28 (7): 137921386.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部